Blueprint Medicines is headquartered at 45 Sidney Street, Cambridge, MA, 02139 USA. The main phone number is 1-617-374-7580.

Blueprint Medicines initial public offering (IPO) occurred on April 30, 2015.

Blueprint Medicines' common stock is traded on the Nasdaq Global Select Market under the symbol BPMC, and the CUSIP number for its common stock is 09627Y 109.

Computershare Trust Company, N.A.
Meidinger Tower
462 South 4th Street
Louisville, KY  40202 
Phone: 1-502-301-6000

December 31.

Blueprint Medicines' SEC filings can be viewed here or at www.sec.gov.

You can submit questions to Blueprint’s investor relations department by contacting ir@blueprintmedicines.com or 617.714.6674